hopemax
Well-Known Member
Ever since the Pfizer and Moderna numbers came out, and the delays/issues with the AZ, I've been assuming that AstraZeneca would turn into the "Covax" vaccine. Rich countries placed large orders originally, but at this point, citizens would probably wait a little longer for the "best" vaccine. Then the rich countries can donate these to developing countries, like the first shipment delivered to Ghana today, for the optics / good global citizen. I thought AZ's numbers are still good enough for the 50% threshold, so it will be effective for slowing down global transmission, but you know how people are when they want to choose. Since they are researching the benefits of giving people multiple vaccines (an mRNA vaccine and then later a traditional one or vice-versa), they could re-vaccinate in the future if conditions warrant it. But it could speed up delivery of any vaccine to some areas, so they might also see good progress in 2021, instead of having to wait until 2022 or 2023.